- Previous Close
1.0000 - Open
0.9900 - Bid 0.9800 x --
- Ask 0.9900 x --
- Day's Range
0.8000 - 0.9900 - 52 Week Range
0.6000 - 1.2000 - Volume
22,025 - Avg. Volume
15,476 - Market Cap (intraday)
33.85M - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
33.00 - EPS (TTM)
0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. It operates through two segments, the Animal Health Business Unit, and the Pharmacy Business Unit. The company engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics. It provides pharmaceuticals, which includes sedaject, ataject, and thyro-tabs canine drugs; and wound care products, including medical tubes, viscose net dressings, elastic bandages, and silicone perforated tapes, as well as medical pet shirt protective wear that comprise pet shirt, pets boot, head cover, and leg sleeves. The company also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, which includes Composure Pro, Vertiflex, hide and treat, L-Lysine Pro, Renal Essentials Pro, and Hepaticlear Pro, as well as Entero Aid +Gi and Fibre Boost +Gi health products. Grey Wolf Animal Health Corp. is headquartered in Toronto, Canada.
greywolfah.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WOLF.V
View MorePerformance Overview: WOLF.V
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WOLF.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WOLF.V
View MoreValuation Measures
Market Cap
33.85M
Enterprise Value
36.02M
Trailing P/E
33.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.17
Price/Book (mrq)
1.29
Enterprise Value/Revenue
1.37
Enterprise Value/EBITDA
10.20
Financial Highlights
Profitability and Income Statement
Profit Margin
3.51%
Return on Assets (ttm)
3.18%
Return on Equity (ttm)
3.57%
Revenue (ttm)
26.3M
Net Income Avi to Common (ttm)
921.89k
Diluted EPS (ttm)
0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
7.07M
Total Debt/Equity (mrq)
35.07%
Levered Free Cash Flow (ttm)
-73.4k